Press Releases

Press Releases

Johnson & Johnson will participate in the 24th Annual Credit Suisse Health Care Conference on Tuesday, Nov. 10, at The Phoenician in Scottsdale, AZ.  Dominic Caruso, Vice President, Finance & Chief Financial Officer will represent the Company in a session scheduled at 10:00 a.m. (Mountain Standard Time). This webcast will…

Press Releases

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that a Memorandum of Understanding (MOU) has been signed with the Government of New South Wales (NSW) in Australia to progress a research program for Epidiolex® (cannabidiol or…

Press Releases

Tyme Technologies, Inc., a research and development company operating through its wholly-owned subsidiary, Tyme Inc., focused on development and eventual commercialization of oncology products, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) Application for SM-88, its breast cancer drug candidate.…

Press Releases

Affinivax Inc., a biotechnology company dedicated to developing novel vaccines, today announced it has entered into a collaboration agreement with Nosocomial Vaccine Corporation (NVC), established by ClearPath Development Company with the support of its partner, Astellas Pharma Inc. The collaboration will utilize Affinivax’s proprietary vaccine platform, Multiple Antigen Presentation System…

Press Releases

PuraCap Pharmaceutical, LLC announced that it has instituted a civil lawsuit against InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc. (collectively, "InvaGen") in the United States District Court for the Southern District of New York, at Civil No. 15-cv-8222.  In its Complaint, PuraCap Pharmaceutical alleges that InvaGen breached certain obligations to…

Press Releases

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today is providing an update on the status of its ophthalmic clinical program in China and Korea. Lee's Pharmaceutical Ltd., RegeneRx's licensee in China, Hong Kong, Macau and Taiwan, received notice from China's FDA (CFDA)…

Press Releases

SQI Diagnostics Inc., today announced a product development agreement with a global pharmaceutical company that formalizes the terms of multiple drug initiatives over the next three years. SQI is a Toronto-based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. SQI's technology…

Press Releases

Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, today announced it has made available a customizable compounded formulation of pyrimethamine and leucovorin available for physicians to consider prescribing for their patients as a low cost alternative to Daraprim®. Last month,…

Press Releases

PharmaEngine, Inc. announced the U.S. FDA has approved Merrimack's (NASDAQ: MACK) ONIVYDE TM (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy on October 22. Earlier on the same day, the…

Press Releases

Yabao Pharmaceutical Co., Inc., a leading pharmaceutical company in China, today announced a second strategic collaboration for the treatment of diabetes with Eli Lilly and Company to co-develop Lilly's sodium-glucose linked transporter inhibitor (SGLT1) molecule. Lilly's SGLT1 inhibitor program has completed a Phase I study in Singapore, in addition to…